Page 695 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 31 Tumors of the Nervous System 673

100. Meij B, Voorhout G, Rijnberk A: Progress in transsphenoidal 121. Platt SR, Nduom E, Kent M, et al.: Canine model of convection-
hypophysectomy for treatment of pituitary-dependent hyperad- enhanced delivery of cetuximab-conjugated iron-oxide nanopar-
renocorticism in dogs and cats, Mol Cell Endocrinol 197:89–96, ticles monitored with magnetic resonance imaging, Clin Neurosurg
VetBooks.ir 101. Meij BP, Auriemma E, Grinwis G, et al.: Successful treatment of 122. Joshi AD, Botham RC, Roth HS, et al.: An oral procaspase acti-
59:107–113, 2012.
2002.
acromegaly in a diabetic cat with transsphenoidal hypophysectomy,
J Feline Med Surg 12:406–410, 2010. vating drug, PAC-1, shows preclinical promise for glioblastoma
therapy, Cancer Res 75:S3620, 2015.
102. Mamelak AN, Owe TN, Bruyette D: Transsphenoidal surgery 123. MacDiarmid JA, Langova V, Bailey D, et al.: Targeted doxorubi-
using a high-definition video telescope for pituitary adenomas cin delivery to brain tumors via minicells: proof of principle using
in dogs with pituitary dependent hypercortisolism: methods and dogs with spontaneously occurring tumors as a model, PLoS One
results, Vet Surg 43:369–379, 2014. 11:e0151832, 2016.
103. Dernell WS, Straw RC, Cooper MF, et al.: Multilobular osteo- 124. Lai S, Koehler J: In vitro anti-tubulin effects of benzimidazole
chondrosarcoma in 39 dogs: 1979-1993, J Am Anim Hosp Assoc anthelmintics mebendazole and fenbendazole on canine glioblas-
34:11–18, 1998. toma cells, J Vet Intern Med 30:1434–1435, 2016.
104. Marino DJ, Dewey CW, Loughin CA, et al.: Severe hyperthermia, 125. Johnson KB, Manhart K, Vite C, et al.: 399 spinal tumors in
hypernatremia, and early postoperative death after transethmoidal dogs, J Vet Intern Med 21:639–640, 2007.
cavitron ultrasonic surgical aspirator (CUSA)-assisted diencephalic 126. Luttgen PJ, Braund KG, Brawner Jr WR, et al.: A retrospective
mass removal in 4 dogs and 2 cats, Vet Surg 43:888–894, 2014. study of 29 spinal tumors in the dog and cat, J Sm Anim Pract
105. Forward AK, Volk HA, De Decker S: Postoperative survival and 21:213–216, 1980.
early complications after intracranial surgery in dogs, Vet Surg 127. Wright JA: The pathological features associated with spinal tumours
47:549–554, 2018. in 29 dogs, J Comp Pathol 95:549–557, 1985.
106. Evans SM, Dayrell-Hart B, Powlis W, et al.: Radiation therapy of 128. Levy MS, Kapatkin AS, Patnaik AK, et al.: Spinal tumors in 37
canine brain masses, J Vet Intern Med 7:216–219, 1993. dogs: clinical outcome and long-term survival (1987-1994), J Am
107. Lester NV, Hopkins AL, Bova FJ, et al.: Radiosurgery using a ste- Anim Hosp Assoc 33:307–312, 1997.
reotactic headframe system for irradiation of brain tumors in dogs, 129. Dernell WS, Van Vechten BJ, Straw R, et al.: Outcome following
J Am Vet Med Assoc 219:1562–1567, 2001. treatment of vertebral tumors in 20 dogs (1986-1995), J Am Anim
108. Bley CR, Sumova A, Roos M, et al.: Irradiation of brain tumors in Hosp Assoc 36:245–251, 2000.
dogs with neurologic disease, J Vet Intern Med 19:849–854, 2005. 130. Roynard PFP, Bilderback A, Falzone C, et al.: Magnetic resonance
109. Spugnini EP, Thrall DE, Price GS, et al.: Primary irradiation of imaging, treatment, and outcome of canine vertebral chondrosar-
canine intracranial masses, Vet Radiol Ultrasound 41:377–380, comas. Six cases, J Sm Anim Pract 57:610–616, 2016.
2000. 131. Petersen SA, Sturges BK, Dickinson PJ, et al.: Canine intraspi-
110. Brearley MJ, Jeffery ND, Phillips SM, et al.: Hypofractionated nal meningiomas: imaging features, histopathologic classification,
radiation therapy of brain masses in dogs: a retrospective analysis and long-term outcome in 34 dogs, J Vet Intern Med 22:946–953,
of survival of 83 cases (1991–1996), J Vet Intern Med 13:408–412, 2008.
1999. 132. Rusbridge C, Wheeler SJ, Lamb CR, et al.: Vertebral plasma cell
111. Mariani CL, Schubert TA, House RA, et al.: Frameless stereotactic tumors in 8 dogs, J Vet Intern Med 13:126–133, 1999.
radiosurgery for the treatment of primary intracranial tumours in 133. Rossmeisl JH, Lanz OI, Waldron DR, et al.: Surgical cytoreduction
dogs, Vet Comp Oncol 13:409–423, 2015. for the treatment of non-lymphoid vertebral and spinal cord neo-
112. Platt SR, Scase TJ, Adams V, et al.: Vascular endothelial growth fac- plasms in cats: retrospective evaluation of 26 cases (1990-2005), Vet
tor expression in canine intracranial meningiomas and association Comp Oncol 4:411–450, 2006.
with patient survival, J Vet Intern Med 20:663–668, 2006. 134. Rissi DR, Barber R, Burnum A, et al.: Canine spinal cord glioma:
113. Dow SW, Lecouteur RA, Rosychuk RA, et al.: Response of dogs a case series and review of the literature, J Vet Diag Invest 29:126–
with functional pituitary macroadenomas and macrocarcinomas to 132, 2017.
radiation, J Small Anim Pract 31:287–294, 1990. 135. Pancotto TE, Rossmeisl JH, Zimmerman K, et al.: Intramedullary
114. Mayer MN, Greco DS, LaRue SM: Outcomes of pituitary tumor spinal cord neoplasia in 53 dogs (1990-2010): distribution, clini-
irradiation in cats, J Vet Intern Med 20:1151–1154, 2006. copathologic characteristics, and clinical behavior, J Vet Intern Med
115. Theon AP, Feldman EC: Megavoltage irradiation of pituitary 3:1500–1508, 2013.
macrotumors in dogs with neurologic signs, J Am Vet Med Assoc 136. Siso S, Marco-Salazar P, Moore PF, et al.: Canine nervous system
213:225–231, 1998. lymphoma subtypes display characteristic neuroanatomical pat-
116. Goossens MM, Feldman EC, Theon AP, et al.: Efficacy of cobalt 60 terns, Vet Pathol 54:53–60, 2017.
radiotherapy in dogs with pituitary-dependent hyperadrenocorti- 137. Marioni-Henry K, Vite CH, Newton AL, et al.: Prevalence of dis-
cism, J Am Vet Med Assoc 212:374–376, 1998. ease of the spinal cord of cats, J Vet Intern Med 18:851–858, 2004.
117. Marcinowska A, Warland J, Brearley M, et al.: Comparison of two 138. Marioni-Henry K, Van Winkle TJ, Smith SH, et al.: Tumors affect-
course fractionated radiation protocols for the management of ing the spinal cord of cats: 85 (1980-2005), J Am Vet Med Assoc
canine pituitary macrotumor: an observational study of 24 dogs, 232:237–243, 2008.
Vet Radiol Ultrasound 56:554–562, 2015. 139. Mandara MT, Motta L, Calo P: Distribution of feline lymphoma
118. LeBlanc AK, Mazcko C, Brown DE, et al.: Creation of an NCI in the central and peripheral nervous systems, Vet J 216:109–116,
comparative brain tumor consortium: informing the translation of 2016.
new knowledge from canine to human brain tumor patients, Neuro 140. Lane SB, Kornegay JN, Duncan JR, et al.: Feline spinal lympho-
Oncol 18:1209–1218, 2016. sarcoma: a retrospective evaluation of 23 cats, J Vet Intern Med
119. Rossmeisl JH: Maximizing local access to therapeutic deliveries 8:99–104, 1994.
in glioblastoma. Part V: Clinically relevant model for testing new 141. Meichner K, Kruse DB, Hirschberger J, et al.: Changes in the prev-
therapeutic approaches. In De Vleeschouwer S, editor: Glioblas- alence of progressive feline leukaemia virus infection in cats with
toma. Brisbane, Codon Publications, 2017, pp 405–425. lymphoma in Germany, Vet Rec 171:348, 2012.
120. Dickinson PJ, LeCouteur RA, Higgins RJ, et al.: Canine spontane- 142. Brewer DM, Cerda-Gonzalez S, Dewey CW, et al.: Spinal cord
ous glioma: a translational model system for convection-enhanced nephroblastoma in dogs: 11 cases (1985-2007), J Am Vet Med Assoc
delivery, Neuro Oncol 12:928–940, 2010. 238:618–624, 2011.